Endometrial Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Endometrial Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma [Phase 2]
This Phase 2 trial investigates nivolumab with or without ipilimumab in mismatch repair–deficient (dMMR) recurrent endometrial cancer and is…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma [Phase 2]
Phase 2 study of ACR-368 in endometrial adenocarcinoma is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: Study of Cadonilimab (AK104) Plus Lenvatinib in Patients With Advanced Endometrial Cancer [Phase 2]
Phase 2 clinical trial evaluating cadonilimab (AK104) in combination with lenvatinib for advanced endometrial cancer; the study is currently…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors [Phase 1, Phase 2]
APL-5125 is being studied in a Phase 1/2 trial for adults with advanced solid tumors, with recruitment ongoing across several indications in…
-
CLINICAL_TRIALS research · 2025-10-14Clinical Trial Update: Study of BMS-986205 and Nivolumab in Endometrial Cancer or Endometrial Carcinosarcoma That Has Not Responded to Treatment [Phase 2]
A Phase 2 clinical trial evaluating the combination of BMS-986205 and nivolumab in patients with endometrial adenocarcinoma or endometrial c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-09-30Clinical Trial Update: Prognosis of METTL-14 in Endometrial Carcinoma
Clinical trial update investigating the prognostic significance of METTL-14 in endometrial carcinoma; the study is currently not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-09-23Clinical Trial Update: Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone [Phase 2]
Phase 2 trial in recurrent or refractory endometrial cancer evaluating Olaparib with Durvalumab, Cediranib with Durvalumab, Olaparib with Ca…
-
CLINICAL_TRIALS research · 2025-07-29Clinical Trial Update: Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers [NA]
A multi-cancer prospective study evaluating double-positive circulating cells (CD45+ tumor marker) in several types of metastatic cancers; r…
-
CLINICAL_TRIALS research · 2025-07-22Clinical Trial Update: Surgical and Obstetric Outcomes in Endometrial Adenocarcinoma and Atypical Endometrial Hyperplasia With Conservative Treatment
A clinical trial evaluating surgical and obstetric outcomes in endometrial adenocarcinoma and endometrial hyperplasia when treated with cons…
-
CLINICAL_TRIALS trial_result · 2025-04-08Clinical Trial Update: QL1706-Based Therapy Post-PD-1/L1 Failure in Advanced Endometrial Cancer [Phase 2]
Phase 2 clinical trial evaluating QL1706-based therapy in advanced endometrial cancer patients who progressed after PD-1/PD-L1 therapy; curr…
-
CLINICAL_TRIALS trial_result · 2025-01-08Clinical Trial Update: Onapristone and Anastrozole for the Treatment of Refractory Hormone Receptor Positive Endometrial Cancer [Phase 2]
Phase 2 clinical trial evaluating the combination of Onapristone and Anastrozole for refractory hormone receptor-positive endometrial cancer…
-
CLINICAL_TRIALS trial_result · 2023-10-26Clinical Trial Update: Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Endometrial Cancer [Phase 2]
A Phase 2 clinical trial investigating radiation therapy with Paclitaxel and Carboplatin in high-risk endometrial cancer was terminated; res…
-
CLINICAL_TRIALS trial_result · 2022-02-17Clinical Trial Update: PEN-866 in Patients With Advanced Solid Malignancies [Phase 1, Phase 2]
Clinical trial update for PEN-866 across multiple phases investigating advanced solid malignancies, including endometrial adenocarcinoma and…
-
CLINICAL_TRIALS trial_result · 2021-11-30Clinical Trial Update: Pembro/Carbo/Taxol in Endometrial Cancer [Phase 2]
Phase 2 trial investigating pembrolizumab, carboplatin, and paclitaxel in endometrial cancer completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-09-13Clinical Trial Update: Megestrol Acetate Plus Metformin to Megestrol Acetate in Patients With Endometrial Atypical Hyperplasia or Early Stage Endometrial Adenocarcinoma [Phase 2]
Phase 2 clinical trial update on megestrol acetate with metformin in endometrial atypical hyperplasia and early-stage endometrial adenocarci…
-
CLINICAL_TRIALS trial_result · 2021-01-12Clinical Trial Update: Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer [Phase 2, Phase 3]
Phase 2/3 trial evaluating paclitaxel and carboplatin with or without metformin in advanced or recurrent endometrial cancer.
-
CLINICAL_TRIALS trial_result · 2020-02-17Clinical Trial Update: Sunitinib Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer [Phase 2]
Phase 2 trial evaluating sunitinib malate in patients with recurrent or metastatic endometrial cancer has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-01-23Clinical Trial Update: Evaluation of Oncoxin-Viusid® in Cervical Cancer and Endometrial Adenocarcinoma. [Phase 2]
Phase 2 clinical trial evaluating Oncoxin-Viusid in cervical cancer and endometrial adenocarcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2020-01-22Clinical Trial Update: Effects of Wound Infiltration With Ketamine Versus Dexmedetomidine Added to Bupivacaine on Cytokines [Phase 4]
Phase 4 clinical trial comparing wound infiltration with ketamine versus dexmedetomidine added to bupivacaine and its effect on cytokines in…
-
CLINICAL_TRIALS trial_result · 2019-07-31Clinical Trial Update: Trastuzumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer [Phase 2]
Phase 2 trial assessing trastuzumab in stage III/IV or recurrent endometrial cancer; study completed.
-
CLINICAL_TRIALS trial_result · 2018-04-05Clinical Trial Update: Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer [Phase 1]
A Phase 1 trial evaluating the combination of dasatinib, paclitaxel, and carboplatin in patients with Stage III-IV or recurrent endometrial …
-
CLINICAL_TRIALS trial_result · 2018-02-27Clinical Trial Update: Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer [Phase 2]
Phase 2 trial evaluating three regimens for endometrial cancer: paclitaxel-carboplatin-bevacizumab, paclitaxel-carboplatin-temsirolimus, and…
-
CLINICAL_TRIALS trial_result · 2017-12-05Clinical Trial Update: Gemcitabine in Treating Patients With Recurrent or Persistent Endometrial Cancer [Phase 2]
Phase 2 trial evaluating gemcitabine in patients with recurrent or persistent endometrial cancer completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer [Phase 2]
Phase 2 clinical trial of trebananib for persistent or recurrent endometrial cancer has completed, with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: Brivanib Alaninate in Treating Patients With Recurrent or Persistent Endometrial Cancer [Phase 2]
A Phase 2 clinical trial of brivanib alaninate in patients with recurrent or persistent endometrial cancer has completed, with results poste…